Form 4 for AXON Axon Enterprise
Accepted 2022-09-28 00:00:00 ET · period of report 2022-09-26 · accession 0001415889-22-010014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-09-28 | 2022-09-26 | AXON | Bagley Brittany | CFO, CBO | A - Grant | $0.00 | +94.6K | 66.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-09-26 | A | A | 28,378 | $0.00 | 94,592 | D | — | — | (F2) Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. 2022 Stock Inducement Plan. The grant will vest one third on September 26, 2023 and then in 8 equal quarterly installments thereafter. |
| 2 | Common | Common Stock | 2022-09-26 | A | A | 66,214 | $0.00 | 66,214 | D | — | — | (F1) Time-vested restricted stock units granted to the reporting person pursuant to the Axon Enterprise, Inc. 2022 Stock Inducement Plan. The grant will vest 20,638 shares each on September 26, 2023 and 2024 and 24,938 shares on September 26, 2025. |